Aleva Neurotherapeutics
Series BAleva Neurotherapeutics raised €5.8M in a Series B round in May 2014. The company is based in Lausanne, Switzerland. Data as of Nov 2026.
Amount raised
€5.8M
€5,776,173
Native amount
8,000,000 USD
Stage
Series B
series b
Investors
0
Provenance & confidence
UnverifiedAmount
8,000,000 USD
ECB-at-date → €5.8M · rate 1.385 on 2014-04-30
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
0 namedNo investors disclosed for this round.
Date
May 2014
Round type
series b
Amount (EUR)
€5.8M